Table 3. Preliminary PK/PD Assessment for Compounds Dosed Orally at 20 mg/kg for up to 10 Days to Mice Infected with T. cruzia.
compd | IC50 (μM) | plasma concn, 0.5 h (μM) | plasma concn, 24 h (μM) | parasites cleared from blood during 10-day dosing? |
---|---|---|---|---|
47 | 0.024 | 3.31 | 0.016 | no |
48 | 0.013 | 1.29 | 0.008 | no |
49 | 0.061 | 3.26 | 0.001 | no |
4 | 0.019 | 2.42 | 0.002 | no |
50 | 0.047 | 5.29 | 0.002 | no |
51 | 0.058 | 3.28 | 0.001 | no |
5 | 0.011 | 0.85 | 0.490 | yes |
2 | 0.012 | 2.49 | 0.030 | yes |
52 | 0.002 | 1.37 | 0.047 | yes |
6 | 0.017 | 5.54 | 0.790 | yes |
(rac)-7 | 0.007 | 1.55 | 0.370 | yes |
posaconazole | 0.001 | 3.04 | 2.89 | yes |
Plasma exposure data were obtained in a parallel group of noninfected mice following a single oral dose of 20 mg/kg.